Skip to main content

Treatment Clinical Trials for Bladder Cancer

Review the bladder cancer treatment clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 101-111 of 111

A Decision Tool for the Selection of Women with Localized Urothelial Bladder Cancer for Reproductive Organ Sparing Radical Cystectomy
Status: Active
Location: UF Health Cancer Institute - Gainesville, Gainesville, Florida
Physical Therapy and Coping Skills Training for Improving Women's Sexual Function after Pelvic Radiation
Status: Active
Location: Duke University Medical Center, Durham, North Carolina
A Precision Oncology Navigation and Expert Review Intervention for Improving Referral to Genome Informed Therapy among Patients with Stage IV Lung, Colorectal, Breast or Bladder Cancers, PROGRESS Trial
Status: Active
Location: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
Status: Active
Location: See ClinicalTrials.gov
Tesetaxel for Previously Treated Patients With Bladder Cancer
Status: Active
Location: See ClinicalTrials.gov
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Status: Active
Location: Case Comprehensive Cancer Center, Cleveland, Ohio
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Status: Active
Location: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia
A Study of DF6002 Alone and in Combination With Nivolumab
Status: Active
Location: See ClinicalTrials.gov
N-803 in Combination with Pembrolizumab and Enfortumab Vedotin for the Treatment of Locally Advanced and Metastatic Urothelial Cancer
Status: Approved
Location: University of California San Francisco, San Francisco, California
Durvalumab and Standard Chemotherapy for the Treatment of Lymph Node Positive Bladder Cancer
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
Pemetrexed and Avelumab in Treating Patients with MTAP-Deficient Metastatic Urothelial Cancer
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas